HALO logo
halo search icon
Decoy Therapeutics Inc.

US$6.43

Price Change Indicator
0.87 (15.65%)
Decoy Therapeutics Inc.
DCOY · NAS

Decoy Therapeutics Inc.

Start Trading DCOY for Free

US$6.43

Price Arrow0.87 (15.65%)
21/05/2026 03:59:57 PM
All-CompaniesAll-ConsensusBig Candle (Realtime)Engulfing BullishEngulfing Bullish (Realtime)HALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Decoy Therapeutics Inc. Overview

DCOY Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Neutral

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About DCOY

icon
icon

Telephone

1.713.913.5608

icon

Address

Suite X, 2450 Holcombe Boulevard, Houston, TX 77021

Description

Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company was founded by Frederick E. Pierce, Barbara Hibner, Peter Marschel, Michael Lipp, and Jodi Cooper in 2020 and is headquartered in Houston, TX.

DCOY Price Chart

Key Stats

Market Cap

US$2.96M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.32 - 415.8

Trade Value (12mth)

US$542,907.00

1 week

26.08%

1 month

2.77%

YTD

-28.94%

1 year

-96.03%

All time high

22338000.00

Key Fundamentals

EPS 3 yr Growth

-99.40%

EBITDA Margin

0.00%

Operating Cashflow

-$5m

Free Cash Flow Return

-130.50%

ROIC

-338.30%

Interest Coverage

0.00

Quick Ratio

2.10

Other Data

Shares Outstanding (Fully Diluted)

1m

HALO Sector

Healthcare

Next Company Report Date

29-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

DCOY Announcements

Latest Announcements

DateAnnouncements
20 May 26
20 May 26
09 May 26
09 May 26
01 May 26

DCOY Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-5,532.49-1,043.06-129.1locklocklock
EPS (Fully Diluted)
 $locklocklocklock-5,532.49-1,043.06-129.1locklocklock
Growth
 %locklocklocklock74.281.187.6locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Decoy Therapeutics Inc. (DCOY:NAS)?
Halo FAQ
The current share price of Decoy Therapeutics Inc. (DCOY:NAS) is USD$6.43.
What is the 52-week high share price for Decoy Therapeutics Inc. (DCOY:NAS)?
Halo FAQ
The 52-week high share price for Decoy Therapeutics Inc. (DCOY:NAS) is USD$415.80.
What is the 52-week low share price for Decoy Therapeutics Inc. (DCOY:NAS)?
Halo FAQ
The 52-week low share price for Decoy Therapeutics Inc. (DCOY:NAS) is USD$4.32.
What is the dividend yield for Decoy Therapeutics Inc. (DCOY:NAS)?
Halo FAQ
Decoy Therapeutics Inc. (DCOY:NAS) does not pay a dividend.
What was Decoy Therapeutics Inc. (DCOY:NAS) last dividend payment?
Halo FAQ
Decoy Therapeutics Inc. (DCOY:NAS) does not pay a dividend.
What is the franking level for Decoy Therapeutics Inc. (DCOY:NAS)?
Halo FAQ
Decoy Therapeutics Inc. (DCOY:NAS) has a franking level of 0.00%.
In which sector is Decoy Therapeutics Inc. (DCOY:NAS) classified?
Halo FAQ
Decoy Therapeutics Inc. (DCOY:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial